The group released a statement today expressing that they are eager to work with Robert F. Kennedy Jr. to eradicate HIV when steps into his role as the Secretary of Health and Human Services.
The HIV + Hepatitis Policy Institute issued a statement today welcoming Robert F. Kennedy Jr.’s confirmation as the next Secretary of Health and Human Services according to a news release.
“We stand ready to work with Secretary Kennedy as he and President Trump seek to improve the health of the American people. Ending infectious and chronic diseases, such as HIV and hepatitis, must be a vital component in the administration’s initiatives,” Carl Schmid, executive director of the HIV+Hepatitis Policy Institute said in the news release. “We were pleased that Kennedy went on record during his confirmation process and stated, ‘I look forward to continuing the good work that President Trump did in his pursuit to eradicate HIV/AIDS.’”
Today’s release also includes a transcript of the Jan. 29 confirmation hearing where Kennedy states, “I believe HIV is the cause of AIDS” and says he supports funding to the Ryan White HIV/AIDS program, specifically, “all appropriate prevention programs, including those which include pre-exposure prophylaxis.”
On Jan. 14, 2025, the organization addressed letters to Senate HELP and Finance Committee members asking them to consider Kennedy’s previous comments that stated he believed AIDS was caused by environmental factors including poppers (amyl nitrite) not HIV. They also added questions to ask when considering his nomination that included:
During his first term, President Trump launched the Ending the HIV Epidemic initiative which aims to reduce the amount of HIV in the United States cases 90% by 2030. The plan relies on four strategies: diagnose, treat, prevent and respond with a focus on the 57 jurisdictions with the highest rates of transmission.
“To deliver on the promise of eradicating HIV will require a commitment to science, properly funded public health treatment and prevention programs, and policies that support all populations impacted by HIV,” Schmid continues. “It will also require access to affordable and comprehensive health coverage, including private insurance, Medicaid and Medicare.”
Trump Budget Axes CDC HIV Prevention, Shifts Care, Experts Warn of Risks
June 10th 2025Although some HIV programs will remain, the proposed cuts in the fiscal year 2026 budget are too severe and will hinder HIV care and research in the United States, according to Carl Schmid, executive director of the HIV+Hepatitis Policy Institute in Washington, D.C.
Read More
Most HIV Patients Trust Their Providers But Don’t Always Feel Heard, Survey Says
May 27th 2025Almost half (48%) of HIV patients sometimes feel unheard by their healthcare providers, which highlights a need for increased disease awareness, according to the early results of a new ViiV Healthcare survey.
Read More
HIV Antiretroviral Reduced Alzheimer’s Risk Continuously, Study Shows
May 8th 2025Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of Alzheimer’s disease by an average of 9% every year, according to new research published in Alzheimer’s and Dementia.
Read More